Atlas Trials

Effect of Dapagliflozin on Microvascular and Macrovascular Circulation and Total Body Sodium Content

Clinical trial NCT02383238 · COMPLETED

Trial details

NCT number
NCT02383238
Sponsor
University of Erlangen-Nürnberg Medical School
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Diabetes Mellitus Type 2
Start date
2014-03-01
Primary completion
2015-10-01
Enrollment
59

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.